UCeed

UCeed, established in 2020 and headquartered in Calgary, Canada, is a venture capital firm managed by Innovate Calgary. It focuses on investing in early-stage, pre-seed and seed-stage companies, primarily in the technology, healthcare, and software sectors. UCeed's mission is to support promising startups, bridging the gap between innovation and commercialization by providing critical early-stage funding.

William Szczepaniak

Managing Director

59 past transactions

Ayrton Energy

Seed Round in 2024
Founded in 2021, Ayrton Energy specializes in developing hydrogen storage technology. Its innovative solution involves storing hydrogen in liquid form, facilitating safe and efficient transportation through existing infrastructures. This technology aims to provide energy security by enabling the use of hydrogen as a fuel for power generation.

SkyAcres Agrotechnologies

Pre Seed Round in 2024
SkyAcres Agrotechnologies is a business that enables individuals and small-scale farmers to convert underutilized spaces into profitable vertical farms. It provides a patent-pending, low-energy aeroponic system that grows a variety of fruits and vegetables without the need for traditional pumps or large investments in land. The company also offers software to manage growing conditions, labor, and compliance, along with branding and packaging services. Through an AI-driven marketplace, SkyAcres connects these growers directly with commercial buyers, ensuring a steady demand for their produce. This model increases food quality, security, and accessibility, while creating positive social and climate impacts.

On A Dime Transformations

Seed Round in 2024
On A Dime Transformations is a specialized operator focused on enhancing addiction recovery outcomes. Its unique program addresses a critical gap in traditional treatment models by integrating employment-based recovery. The company's approach aims to provide individuals in recovery with meaningful employment opportunities, fostering a sense of purpose and facilitating a smoother transition into a productive, work-driven life.

AgGene

Pre Seed Round in 2024
AgGene is an agricultural biotechnology company focused on developing plant traits to address crop production challenges. Its flagship GTPase accelerating protein technology enhances protein content in plant tissues, aiming to improve protein yields.

Noa Therapeutics

Pre Seed Round in 2024
Noa Therapeutics is a preclinical biotechnology company specializing in the development of innovative, multimodal treatments for immune diseases. The company's approach involves creating a single, non-steroidal, small molecule with adjustable potency, targeting three distinct therapeutic pathways to simplify and enhance patient care.

Brave Technology Coop

Seed Round in 2024
Brave is a technology co-op on a mission to end overdose fatalities. We make overdose detection tools that identify overdoses and activate life-saving community response. Our tools have been used more than 10,000 times and saved more than 100 lives to date. We co-design our products with people who use drugs so that overdose detection and response are accessible to everyone, especially those most at risk. Public health and housing groups, supportive housing buildings, acute and community care centers, civic spaces, and businesses license Brave technology to prevent fatal overdoses in their communities. The broad problem we are solving is the fact that if someone uses drugs alone, they will die if they overdose. That's a preventable death, a reversible situation, if someone gets there in time. One of the reasons why this problem is not being solved and the burden falls on us is because people confuse the problem of overdose death with something else: they think the problem is drug use in general, so they increase funding to law enforcement, or they think it's substance use disorder, so they focus on recovery tools, or, worst of all, they think that drug users don't warrant our support or efforts, so they only focus on educating children to stay away from drugs. But the problem is that people are dying preventable deaths. And all we need to do is look at those deaths closely

Altiro Energy

Pre Seed Round in 2023
Altiro Energy is a renewable energy company specializing in clean technology power systems. It develops iron-based powder energy storage solutions for wind and solar farms, enabling stable production and reduced waste during periods of excess supply.

Jump Math

Seed Round in 2023
JUMP Math is a numeracy program and enhancing the potential in children by encouraging an understanding of math in students and educators.

Probius

Seed Round in 2023
Probius is a company that focuses on the development of an electronic sensing platform that offers comprehensive diagnostic services. This platform enables the real-time analysis of multiple target proteins, facilitating broad-spectrum and point-of-care diagnostics. Probius' technology is particularly beneficial in emergency care settings, allowing for blood-draw quality checks and the implementation of broad screening panels. By providing timely and accurate diagnostic information, Probius empowers healthcare professionals to deliver appropriate therapy to patients in critical care situations, enhancing the overall quality of medical treatment. Additionally, the company specializes in biomarker discovery and quantification, further contributing to advancements in diagnostic capabilities.

Sequence2Script

Pre Seed Round in 2023
Sequence2Script is a technology company specializing in healthcare. It offers a web-based tool designed to assist clinical laboratories and healthcare professionals in transforming pharmacogenetic test results into practical medication and dosing recommendations. The tool consolidates and updates relevant research, enabling users to interpret complex genetic data and make informed, precision-based prescribing decisions.

XN Health

Seed Round in 2023
XN Health is a medical device company founded in 2021 and based in Texas, USA. The company focuses on developing innovative healthcare solutions to assist mechanically ventilated patients in weaning off ventilators more efficiently. Its primary product utilizes phrenic nerve stimulation to induce diaphragm contractions, thereby mitigating the risks of diaphragm dysfunction associated with prolonged mechanical ventilation. By enhancing the weaning process, XN Health aims to improve patient outcomes and facilitate recovery in critical care settings.

Litus

Seed Round in 2023
Litus specializes in nanotechnology applications for energy solutions. It focuses on selectively extracting lithium from aqueous sources using proprietary chemical processes.

Hyperlume

Pre Seed Round in 2023
Hyperlume Inc., based in Ottawa, Canada, specializes in developing advanced optical connectivity solutions. The company focuses on high-performance computing, artificial intelligence, and high-end processors, aiming to enhance data transfer speeds and enable scalable optical interconnects for edge computing platforms.

HelpSeeker Technologies

Seed Round in 2023
HelpSeeker Technologies specializes in digital solutions for complex social issues. Its platform offers customizable case management software, streamlining workflows and connecting individuals in need with appropriate social services.

Monark

Seed Round in 2023
Monark is a digital leadership guide that enables growth through one simple app. Monark provides a full-cycle, tailored, and integrated experience to leaders of all levels. Their patented platform and micro-content are accessible anywhere, at any time, and on any device.

Monark

Seed Round in 2023
Established in 2001, Monark specializes in real estate development and e-commerce business models, also offering consulting services for businesses. Based in Surrey, BC.

True Angle

Seed Round in 2023
True Angle is an Alberta-based medical technology company located in Edmonton, Canada, focused on improving the quality of life for individuals with swallowing disorders. The company has developed the Mobili-T, a mobile device that enables users to perform necessary exercises at home, enhancing their ability to eat safely. This innovative solution is supported by an engaging app that tracks muscle contractions and provides feedback, guiding users to meet specific rehabilitation targets set by the device's smart software. In addition to addressing swallowing difficulties, True Angle aims to support remote care delivery solutions that contribute to overall well-being, particularly as individuals age.

Xploro

Seed Round in 2023
Xploro is a healthcare platform that uses augmented reality, gameplay, and artificial intelligence to deliver health information to young patients. Its interactive, engaging content empowers patients, reduces stress and anxiety, and improves clinical outcomes.

Fledge

Pre Seed Round in 2023
Fledge is an online platform gamifying mental health for children aged K to 3. It equips them with foundational life skills through engaging activities that mitigate anxiety, improve focus, and develop self-regulation. The platform aims to reduce the burden on caregivers by providing accessible, simple-to-use resources, allowing more time for authentic connections.

KnowHow

Seed Round in 2023
KnowHow is a software company focused on enhancing the efficiency of blue-collar businesses. It offers a platform that provides clients with step-by-step processes necessary for effective job execution. By creating, sharing, and tracking internal procedures, KnowHow's solution helps eliminate confusion and improve employee productivity. The platform is designed to save time and reduce errors, ultimately increasing profitability for its users by enabling them to better manage tasks and deliverables while safeguarding their time and resources.

Retinalogik

Pre Seed Round in 2023
Retinalogik is a medical technology company that develops innovative vision screening solutions. They specialize in creating intelligent, portable devices designed to prevent vision loss by making comprehensive eye exams accessible and affordable for everyone. Their platform enables early detection of various eye conditions, ensuring users maintain clear vision at reduced costs.

Ayrton Energy

Pre Seed Round in 2023
Founded in 2021, Ayrton Energy specializes in developing hydrogen storage technology. Its innovative solution involves storing hydrogen in liquid form, facilitating safe and efficient transportation through existing infrastructures. This technology aims to provide energy security by enabling the use of hydrogen as a fuel for power generation.

PulseMedica

Seed Round in 2023
PulseMedica is a medical device company based in Edmonton. It develops non-invasive, automated image-guided laser treatments for vitreoretinal diseases using 3D computer vision and femtosecond laser technology.

Alto

Seed Round in 2023
Making finding home care easier, safer and more affordable.

Nimble Science

Seed Round in 2023
Nimble Science Ltd. is a digital health company focused on revolutionizing gastrointestinal (GI) health through its innovative SIMBA capsule technology. This end-to-end platform facilitates multi-omic mapping of the GI tract, allowing for the passive sampling of small bowel luminal fluid. By leveraging this advanced sampling method, Nimble Science provides precision datasets that offer valuable insights into GI health, thereby transforming the diagnosis and treatment of gastrointestinal conditions. The company's approach enables healthcare providers to directly sample and analyze targeted regions of the GI tract, marking a significant advancement in the understanding and management of GI health.

3E Nano

Seed Round in 2023
Founded in 2006, 3E Nano develops and commercializes Diamond-Like Carbon (DLC) coatings for transparent media. These coatings are designed to control heat and light emission, targeting applications such as windows, windshields, greenhouses, and solar modules.

Oncoustics

Seed Round in 2023
Oncoustics develops AI-enhanced ultrasound technology to analyze raw ultrasound signals from handheld devices, enabling rapid differentiation between healthy and diseased tissue. The approach generates novel acoustic biomarkers and supports non-invasive surveillance, diagnostics, and treatment monitoring for diseases with high unmet clinical needs. The company aims to improve clinical workflow productivity and has pursued regulatory pathways such as FDA Breakthrough Device designation for its OnX liver fibrosis detection, with 510(k) submission in progress, and plans for follow-on liver and other organ indications including prostate, kidney, breast and thyroid diseases and cancers.

Child Health Imprints

Seed Round in 2023
Child Health Imprints specializes in applying advanced technologies such as IoT, AI, and predictive analytics to enhance neonatal intensive care worldwide. Its core focus is improving early disease diagnosis and overall healthcare quality for neonates.

Shoelace Learning

Seed Round in 2022
Shoelace Learning develops educational software that delivers research-based, adaptive reading comprehension practice through engaging multiplayer games. Its platform motivates children to learn while providing teachers with tools to assess progress, identify skill gaps, and create assignments.

MACH32

Pre Seed Round in 2022
MACH32 develops medical devices and drug-delivery solutions for pre-hospital and urgent-care trauma treatment. It designs safe, reliable tools that enable healthcare professionals to treat patients in the field while using protective equipment to reduce exposure to infectious aerosols, supporting rapid and safer intervention in emergency situations.

Difinity Solutions

Pre Seed Round in 2022
Difinity Solutions specializes in developing and commercializing innovative medication delivery systems for critical situations such as opioid overdose and anaphylaxis. They offer a range of services including medical, engineering, regulatory, and technology support to optimize patient outcomes and enhance emergency care.

ViTAA Medical Solutions

Seed Round in 2022
ViTAA Medical Solutions specializes in personalized medicine focused on the non-invasive assessment of abdominal aortic aneurysms. The company utilizes advanced technology to map regional areas of weakness in the aorta wall, analyzing deformation through images captured during the cardiac cycle. Their cloud-based platform, enhanced by integrated artificial intelligence, aims to improve patient management and treatment for those with aortic aneurysms. By providing physicians with detailed insights, ViTAA enables healthcare professionals to make informed decisions, ensuring that patients receive timely and appropriate care tailored to their specific conditions.

AllSkin Dermatology

Pre Seed Round in 2022
AllSkin Dermatology specializes in comprehensive dermatological care, offering treatments for skin cancer, acne, and various skin diseases. They employ advanced technology to develop personalized treatment plans.

Cadence

Seed Round in 2022
Cadence is a digital aftercare concierge service that assists bereaved families in managing estate settlement tasks. The platform streamlines and automates the estate management process by providing personalized guidance and utilizing form automation. This enables users to navigate the necessary applications and notifications efficiently. Once the required parties digitally sign the documents, Cadence ensures secure distribution and tracking of submissions. By offering location-specific guidance and comprehensive advice, Cadence aims to save time and help maintain important relationships between individuals, businesses, and their clients or beneficiaries.

Areto Labs

Pre Seed Round in 2022
Areto Labs develops automated social media moderation software that uses AI to filter spam, abuse, and illegal content. This helps media organizations and content creators maintain regulatory compliance, enhance audience engagement, safeguard user experience, identify key followers, and streamline moderation workflows.

Included by Design

Pre Seed Round in 2022
Included by Design offers accessibility consulting services, connecting businesses with resources to create inclusive spaces for people with disabilities. They provide a community map and marketplace for accessible venues, along with guidance on navigating accessibility standards.

Medhesion

Pre Seed Round in 2022
Medhesion is a medical therapeutic drug company

LyfeMD

Seed Round in 2022
LyfeMD is a wellness application focused on managing inflammatory bowel disease through a holistic approach to digestive health. The company offers a platform that provides customized, doctor-recommended advice tailored to each patient's specific needs. This includes disease-specific nutrition plans, recipes, and guidance on physical activities and yoga-based therapies. By integrating these components, LyfeMD enables patients to make informed nutrition and lifestyle changes that complement their medical treatments, ultimately promoting improved health and well-being.

Stagehand

Seed Round in 2022
Stagehand is a company that has developed an application aimed at transforming the live music experience. This web-based platform connects performers with venues, facilitating the scheduling and promotion of live events. By focusing on the grassroots arts community, Stagehand enhances collaboration among local artists and venues, making it easier for non-traditional music projects to flourish. The application serves to enrich the customer experience by streamlining the process of booking and advertising live performances, thereby supporting the local arts scene.

Circle Neurovascular Imaging

Seed Round in 2022
Developer of AI-powered medical imaging software designed to augment acute stroke diagnosis. The software predicts aspects of NCCT, detects large vessel occlusion on CTA, and facilitates remote access to imaging for quicker decision-making.

PulseMedica

Seed Round in 2022
PulseMedica is a medical device company based in Edmonton. It develops non-invasive, automated image-guided laser treatments for vitreoretinal diseases using 3D computer vision and femtosecond laser technology.

Reach Orthopaedics

Pre Seed Round in 2021
Reach Orthopaedics develops a patent-approved orthopedic shoulder implant designed to treat massive irreparable rotator cuff tears. The device aims to restore shoulder function and reduce chronic pain by correcting joint imbalances and lowering the risk of progressive osteoarthritis. Founded by orthopaedic surgeons, the company targets patients across ages and seeks to streamline recovery through a design intended to shorten surgery duration and improve outcomes.

PulseMedica

Seed Round in 2021
PulseMedica is a medical device company based in Edmonton. It develops non-invasive, automated image-guided laser treatments for vitreoretinal diseases using 3D computer vision and femtosecond laser technology.

Fluid Biomed

Seed Round in 2021
Fluid Biomed is a medical device start-up specializing in the development of an innovative implantable dissolving stent aimed at treating brain aneurysms. Founded by a team of neurosurgeons, the company focuses on enhancing patient outcomes by offering a bio-absorbable polymer-based flow-diverting stent that gently redirects blood flow to facilitate the healing of weakened blood vessels. This advanced medical device is designed to minimize the need for invasive procedures, allowing physicians to efficiently and effectively treat patients while reducing the risk of stroke. Through its pioneering approach, Fluid Biomed is poised to contribute significantly to the field of neurosurgery and improve the quality of care for individuals with brain aneurysms.

Chroma Technologies

Funding Round in 2021
Chroma Technologies provides financial technology and property solutions to enhance the rental experience. ChromaRent, the company's flagship product, is a payment alternative in which Chroma pays rent on renters' behalf on the first of the month, and renters can choose when and how they pay Chroma back throughout the month, with on-time payments also contributing to their credit score in the near future. Chroma's mission is to provide renters with simple financial products that improve their lives.

HelpWear

Pre Seed Round in 2021
HelpWear develops a waterproof wearable device that monitors heart activity, detects heart attacks, and sends real-time alerts to medical facilities. Incorporated in 2015, the company is based in Toronto, Canada.

PurposeMed

Seed Round in 2021
PurposeMed is a telehealth company dedicated to improving access to complex healthcare for underserved communities. By integrating advanced technology with a thoughtful design approach, PurposeMed aims to eliminate barriers that often hinder individuals from receiving high-quality care. The company focuses on providing affirming and compassionate healthcare, allowing patients to connect with skilled clinicians without the constraints of traditional waiting rooms. This innovative model enables patients to receive care from the comfort of their homes, ensuring that even the most vulnerable populations can access the medical attention they need in a timely and supportive environment.

Trexo Robotics

Seed Round in 2021
Trexo Robotics develops robotic mobility devices for individuals with physical impairments. Their flagship product is designed specifically for children, aiming to enhance walking mobility through repetitive motion therapy and user-centric design.

Syantra

Seed Round in 2021
Syantra is a precision biotechnology company focused on transforming cancer detection and treatment, with an emphasis on breast cancer. Its flagship Syantra DX Breast Cancer is a blood-based test for early screening that analyzes a panel of gene expression biomarkers from whole blood and employs machine learning to yield a positive or negative result. The company also develops the Onco-ID platform to broaden early cancer detection across multiple cancer types. In addition to breast cancer, its devices offer a blood-based cancer detection assay that uses a novel biomarker set and AI-driven interpretation to support clinicians in diagnosis. The overall aim is to provide healthcare providers with tools for earlier, more accurate detection of cancer.

Cohesic

Seed Round in 2021
Cohesic is a Decision Intelligence company specializing in clinical decision support solutions for chronic disease diagnosis and management. Its platform enhances cardiovascular care through data-driven diagnostic workflows and structured reporting software, improving reporting efficiency, reducing medical errors, and providing insights into patient health.

Tactile Orthopaedics

Seed Round in 2021
Tactile Orthopaedics develops innovative medical training systems that replicate knee anatomy and provide realistic tactile feedback. Their platforms include dynamic knee models for arthroscopy and arthroplasty, designed to enhance surgical skills without risks associated with traditional methods.

Deep Surface AI

Pre Seed Round in 2021
Deep Surface AI develops intelligent morphing software that uses advanced machine learning algorithms to generate personalized, realistic 3D visualizations for facial aesthetics. This enables surgeons to provide patients with detailed, accurate representations of potential cosmetic surgery outcomes.

Nimble Science

Pre Seed Round in 2021
Nimble Science Ltd. is a digital health company focused on revolutionizing gastrointestinal (GI) health through its innovative SIMBA capsule technology. This end-to-end platform facilitates multi-omic mapping of the GI tract, allowing for the passive sampling of small bowel luminal fluid. By leveraging this advanced sampling method, Nimble Science provides precision datasets that offer valuable insights into GI health, thereby transforming the diagnosis and treatment of gastrointestinal conditions. The company's approach enables healthcare providers to directly sample and analyze targeted regions of the GI tract, marking a significant advancement in the understanding and management of GI health.

AazeinTx

Pre Seed Round in 2021
AazeinTx is a biotechnology company focused on developing innovative treatments for asthma. The company has created a platform that offers an oral treatment specifically designed to address acute asthma. Its technology targets the nervous system to prevent asthmatic attacks while simultaneously reducing lung inflammation, thereby decreasing the likelihood of future attacks. This approach aims to enhance overall lung health for patients, providing a proactive solution for managing asthma symptoms and improving quality of life.

Zymedyne Therapeutics

Seed Round in 2021
Zymedyne Therapeutics is a biopharmaceutical company focused on developing non-opioid treatments for chronic, neuropathic pain. The company targets human calcium channels that play a critical role in pain signaling, holding a patent for a newly discovered molecular mechanism that increases the expression of T-type calcium channels, leading to heightened pain signals. By creating therapies that do not rely on opioids, Zymedyne aims to offer safer pain-relieving alternatives, addressing the need for effective pain management without the harmful side effects associated with opioid use.

Innovere Medical

Pre Seed Round in 2020
Innovere Medical specializes in developing wireless peripheral devices for Magnetic Resonance Imaging (MRI) applications. Their primary product is an interactive TV designed to operate within MRI scanners, providing clear audio signals and reducing noise, thereby enhancing patient comfort and communication between healthcare providers.

Qualisure Diagnostics

Pre Seed Round in 2020
Qualisure Diagnostics is a biotechnology company focused on making precision oncology the standard of care through the development of innovative diagnostic tools. The company harnesses big data and machine learning, utilizing proprietary algorithms to analyze extensive genomic databases and identify key biomarkers linked to patient survival outcomes. This capability allows for the creation of diagnostic tests that provide oncologists with vital biological information to tailor cancer treatment plans effectively. By minimizing unnecessary surgeries and treatments, Qualisure Diagnostics aims to enhance patient outcomes while also reducing healthcare costs. Their cloud-based platform enables global deployment of these diagnostic tests, supported by a central marketplace that simplifies test selection, ordering, and data exchange among healthcare stakeholders. Ultimately, Qualisure Diagnostics empowers physicians, patients, and other test developers with actionable insights, contributing to a more effective and efficient cancer care approach.

Nimble Science

Venture Round in 2019
Nimble Science Ltd. is a digital health company focused on revolutionizing gastrointestinal (GI) health through its innovative SIMBA capsule technology. This end-to-end platform facilitates multi-omic mapping of the GI tract, allowing for the passive sampling of small bowel luminal fluid. By leveraging this advanced sampling method, Nimble Science provides precision datasets that offer valuable insights into GI health, thereby transforming the diagnosis and treatment of gastrointestinal conditions. The company's approach enables healthcare providers to directly sample and analyze targeted regions of the GI tract, marking a significant advancement in the understanding and management of GI health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.